Related Experiment Video
Updated: Apr 22, 2026
04:22
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
7.2K
Inhaled antibiotics: dry or wet?
Harm A W M Tiddens1, Aukje C Bos2, Johan W Mouton3
1Erasmus MC-Sophia Children's Hospital, Dept of Pediatric Pulmonology and Allergology, Rotterdam, The Netherlands Erasmus MC, Dept of Radiology, Rotterdam, The Netherlands h.tiddens@erasmusmc.nl.
The European Respiratory Journal
|October 18, 2014
Summary
Dry powder inhalers (DPIs) offer a faster alternative to nebuliser therapy for cystic fibrosis patients. Patient technique and individual factors significantly impact the effectiveness of both DPI and nebuliser antibiotic delivery.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Biomedical Engineering
Background:
- Dry powder inhalers (DPIs) are emerging as a more efficient alternative to traditional nebuliser therapy for antibiotic delivery in cystic fibrosis (CF) patients.
- Studies indicate noninferiority of inhaled tobramycin via DPI compared to nebulisation for treating Pseudomonas aeruginosa.
- Significant differences exist between DPI and nebuliser delivery systems, necessitating a deeper understanding of their comparative efficacy.
Purpose of the Study:
- To explore how inhalation technique and patient-specific factors influence the efficacy of antibiotics delivered via DPI versus nebulisers.
- To highlight the importance of understanding aerosol delivery differences for personalized CF treatment.
- To provide guidance for healthcare professionals on optimizing inhaled antibiotic therapy.
Main Methods:
- Review of current literature on aerosol therapy and inhaled antibiotic delivery systems.
- Analysis of factors influencing drug deposition in the lungs, including airway generation and structural lung changes.
- Comparative discussion of the advantages and disadvantages of dry powder inhalers and nebulisers for antibiotic administration.
Main Results:
- While noninferiority studies show similar efficacy for inhaled tobramycin, patient-related factors and inhalation technique can significantly alter outcomes.
- Differences in aerosol characteristics (dry vs. wet) impact local antibiotic concentrations within the airways.
- Understanding these variables is crucial for effective treatment personalization and patient instruction.
Conclusions:
- Healthcare providers must be aware of the nuances between DPI and nebuliser therapies to tailor treatment effectively.
- Personalized patient instruction and consideration of individual factors are key to optimizing inhaled antibiotic efficacy.
- Further research into optimizing aerosol delivery methods can improve outcomes for cystic fibrosis patients.
More Related Videos
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
1.7K
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
42.0K
Related Concept Videos
01:23Inhaled Medications
1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
01:18Additional Routes of Drug Administration
4.8K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.8K
01:16Drugs Used in Upper Respiratory Disorders: Overview
995
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
995
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
01:22Drug Delivery: Miscellaneous Routes
1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
01:15Non-Oral Extravascular Drug Absorption Routes
712
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
712